Literature DB >> 29607295

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer.

Scott T Eblen1, Amber Bradley1.   

Abstract

Entities:  

Year:  2017        PMID： 29607295      PMCID： PMC5878060          DOI： 10.21037/tcr.2017.02.01

Source DB:  PubMed          Journal:  Transl Cancer Res        ISSN： 2218-676X            Impact factor:   1.241


× No keyword cloud information.
  20 in total

1.  MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains.

Authors:  K O Tan; K M Tan; S L Chan; K S Yee; M Bevort; K C Ang; V C Yu
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

2.  The E3 ubiquitin ligase EDD regulates S-phase and G(2)/M DNA damage checkpoints.

Authors:  Marcia A Munoz; Darren N Saunders; Michelle J Henderson; Jennifer L Clancy; Amanda J Russell; Gillian Lehrbach; Elizabeth A Musgrove; Colin K W Watts; Robert L Sutherland
Journal:  Cell Cycle       Date:  2007-09-07       Impact factor: 4.534

3.  TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination process.

Authors:  San San Lee; Nai Yang Fu; Sunil K Sukumaran; Kah Fei Wan; Qian Wan; Victor C Yu
Journal:  Exp Cell Res       Date:  2008-12-09       Impact factor: 3.905

4.  The RASSF1A tumor suppressor activates Bax via MOAP-1.

Authors:  Michele D Vos; Ashraf Dallol; Kristin Eckfeld; Nadia P C Allen; Howard Donninger; Luke B Hesson; Diego Calvisi; Farida Latif; Geoffrey J Clark
Journal:  J Biol Chem       Date:  2005-12-12       Impact factor: 5.157

5.  EDD mediates DNA damage-induced activation of CHK2.

Authors:  Michelle J Henderson; Marcia A Munoz; Darren N Saunders; Jennifer L Clancy; Amanda J Russell; Brandi Williams; Darryl Pappin; Kum Kum Khanna; Stephen P Jackson; Robert L Sutherland; Colin K W Watts
Journal:  J Biol Chem       Date:  2006-10-30       Impact factor: 5.157

6.  Distinct functional domains of PNMA5 mediate protein-protein interaction, nuclear localization, and apoptosis signaling in human cancer cells.

Authors:  Yong Hoi Lee; Siew Wai Pang; Chit Laa Poh; Kuan Onn Tan
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-16       Impact factor: 4.553

7.  The Trim39 ubiquitin ligase inhibits APC/CCdh1-mediated degradation of the Bax activator MOAP-1.

Authors:  Nai-Jia Huang; Liguo Zhang; Wanli Tang; Chen Chen; Chih-Sheng Yang; Sally Kornbluth
Journal:  J Cell Biol       Date:  2012-04-23       Impact factor: 10.539

8.  The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro.

Authors:  P M O'Brien; M J Davies; J P Scurry; A N Smith; C A Barton; M J Henderson; D N Saunders; B S Gloss; K I Patterson; J L Clancy; V A Heinzelmann-Schwarz; Rajmohan Murali; R A Scolyer; Y Zeng; E D Williams; L Scurr; A Defazio; D I Quinn; C K W Watts; N F Hacker; S M Henshall; R L Sutherland
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

9.  Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.

Authors:  K Matsuura; N-J Huang; K Cocce; L Zhang; S Kornbluth
Journal:  Oncogene       Date:  2016-10-10       Impact factor: 9.867

10.  Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase.

Authors:  Subbareddy Maddika; Junjie Chen
Journal:  Nat Cell Biol       Date:  2009-03-15       Impact factor: 28.824
View more
  5 in total

1.  Prolactin-inducible EDD E3 ubiquitin ligase promotes TORC1 signalling, anti-apoptotic protein expression, and drug resistance in breast cancer cells.

Authors:  Tyler M MacDonald; Lynn N Thomas; Emily Daze; Paola Marignani; Penelope J Barnes; Catherine Kl Too
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

2.  CircUBR5 acts as a ceRNA for miR-1179 to up-regulate UBR5 and to promote malignancy of triple-negative breast cancer.

Authors:  Guohua Gong; Jikai She; Danni Fu; Dong Zhen; Bin Zhang
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

3.  Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.

Authors:  Mei Song; Oladapo O Yeku; Sarwish Rafiq; Terence Purdon; Xue Dong; Lijing Zhu; Tuo Zhang; Huan Wang; Ziqi Yu; Junhua Mai; Haifa Shen; Briana Nixon; Ming Li; Renier J Brentjens; Xiaojing Ma
Journal:  Nat Commun       Date:  2020-12-08       Impact factor: 14.919

Review 4.  The emerging roles of E3 ubiquitin ligases in ovarian cancer chemoresistance.

Authors:  Yang Meng; Lei Qiu; Su Zhang; Junhong Han
Journal:  Cancer Drug Resist       Date:  2021-06-19

5.  UBR5 oncogene as an indicator of poor prognosis in gastric cancer.

Authors:  Fanghui Ding; Xiaoliang Zhu; Xiaojing Song; Pei Yuan; Longfei Ren; Changpeng Chai; Wence Zhou; Xun Li
Journal:  Exp Ther Med       Date:  2020-08-25       Impact factor: 2.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.